Shikha Gupta, PhD, discussed the mechanistic rationale for combining palbociclib and RMC-5552 in translocation renal cell carcinoma (tRCC).
Shikha Gupta, PhD
Advertisement
Articles by Shikha Gupta, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Melanoma Vaccine Receives FDA Fast Track Designation
2
NCCN Guidelines Recommend Taletrectinib for ROS1+ NSCLC Subtype
3
Targeting NAMPT and KRAS in Pancreatic Ductal Adenocarcinoma
4
145 Racial Differences in Outcomes and Health Care Utilization Among Patients With HR-Positive, HER2-Negative Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: A Real-World Analysis
5